AbbVie Inc./ US00287Y1091 /
| 3/21/2023 1:20:50 PM | Chg. -0.0600 | Volume | Bid9:57:08 PM | Ask9:57:08 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 145.0400EUR | -0.04% | 17 Turnover: 2,475.0800 |
145.4000Bid Size: 80 | 145.7000Ask Size: 80 | 257.6 bill.EUR | - | - |
Newsfile Corp
5/16/2022
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AbbVie Inc. Investors With Losses to Secure Counsel Befor...
Newsfile Corp
4/23/2022
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Be...
Newsfile Corp
4/22/2022
ROSEN, A TOP RANKED LAW FIRM, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before ...
Newsfile Corp
4/21/2022
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AbbVie Inc. Investors With Losses to Secure Counsel B...
Newsfile Corp
4/19/2022
ROSEN, NATIONAL TRIAL LAWYERS, Encourages AbbVie Inc. Investors to Secure Counsel Before Important D...
Newsfile Corp
4/17/2022
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AbbVie Inc. Investors with Losses Exceeding $100K to Sec...
Newsfile Corp
4/15/2022
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages AbbVie Inc. Investors with Losses to Secure Counsel Be...
Newsfile Corp
4/13/2022
ABBV LOSS ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages AbbVie Inc. Investors with Losses to S...
GlobeNewswire
3/28/2022
Triller, Who Recently Announced a Go-Public Transaction With Nasdaq Listed SEAC, to Acquire Fast-Gro...
GlobeNewswire
3/28/2022
HCW Biologics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights fo...
GlobeNewswire
3/25/2022
Morphic Therapeutic Announces Initiation of EMERALD-1 Phase 2a Clinical Trial of MORF-057 in Patient...
GlobeNewswire
3/24/2022
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
GlobeNewswire
3/24/2022
Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage of its...
GlobeNewswire
3/23/2022
CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors
GlobeNewswire
3/21/2022
Caribou Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corpora...
GlobeNewswire
3/18/2022
Nitrase Therapeutics Announces Major Discovery In Parkinson’s Disease Presented At The AD/PD Interna...
GlobeNewswire
3/17/2022
CytomX Therapeutics to Present Updated Preclinical Data for Conditionally Activated Cytokine Program...
GlobeNewswire
3/17/2022
Synlogic Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
GlobeNewswire
3/10/2022
Harpoon Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corpor...
GlobeNewswire
3/8/2022
Voyager Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
GlobeNewswire
3/8/2022
Inventiva announces that its IND application for the Phase II combination trial with lanifibranor a...
GlobeNewswire
3/7/2022
Inventiva reports its 2021 Full-Year Results: key milestones achieved with lanifibranor in NASH and ...